Magellan Laboratories Provides GFAAS Testing to Help Manufacturers with Aluminum Content Testing.

The Food and Drug Administration is requiring that all manufacturers of Small Volume Parenterals (SVPs) and Pharmacy Bulk Packages (PBPs) used in the preparation of Total Parenteral Nutritional Products (TPNs) submit validated methods to the FDA for their aluminum content (Federal register Vol. 65, No. 17, Wednesday, January 26, 2000). These companies must also label the aluminum contents of these products by January 26, 2001.

Magellan Laboratories has extensive experience in GFAAS (Graphite Furnace Atomic Absorption Spectroscopy), the main method listed by the FDA for determining aluminum content, as well as ICP-MS, ICP-AES, and FAAS capabilities. Magellan Laboratories is currently assisting many manufacturers with this testing and is emerging as the premier contract laboratory working in this area.

For more information on this requirement and how Magellan may be of assistance to you, feel free to give us a call at (919) 481-4855.